POSSIBILITIES OF CALCULATING THE RISK OF DEVELOPING MACROSOMIA IN GESTATIONAL DIABETES MELLITUS
Main Article Content
Abstract
Underestimation of accelerated fetal growth during pregnancy complicated by gestational diabetes mellitus leads to short-term and long-term complications for the mother and the newborn. The work is aimed at finding factors that, at the stage of antenatal diagnosis, will improve perinatal outcomes in pregnant women with gestational diabetes mellitus.
The aim of the study was to create an online calculator for calculating the risk of fetal macrosomia in women with gestational diabetes mellitus.
Materials and methods of the study. During 2022-2024, a case-control study (n = 400) was conducted, which examined anamnestic, laboratory, clinical and paraclinical risk factors for the development of macrosomia in women whose pregnancy was complicated by gestational diabetes mellitus (n = 200) and without carbohydrate metabolism disorders (n = 200). Based on the results of binary logistic regression, two independent laboratory and paraclinical risk factors for the development of this complication in patients with gestational diabetes mellitus were identified.
Results. Glycated hemoglobin at the time of registration for pregnancy and the LF index of the fetus at the first sample in the study of maternal and fetal heart rate variability are the main indicators influencing the development of fetal macrosomia.
Keywords
Article Details
Information about financing and conflict of interests
The authors declare that they have no apparent or potential conflicts of interest related to the publication of this article.
This work is licensed under a Creative Commons Attribution 4.0 License.
How to Cite
References
Gestational diabetes mellitus. Clinical guidelines of the Russian Federation 2024. 54 p. Russian (Гестационный сахарный диабет. Клинические рекомендации РФ 2024. 54 с.)
Wang Y-W, Chen Y, Zhang Y-J. Risk factors combine in a
complex manner in assessment for macrosomia. BMC Public Health. 2023; 23(1): 271. doi: 10.1186/s12889-023-15195-9
Harvey L, van Elburg R, van der Beek EM. Macrosomia and
large for gestational age in Asia: One size does not fit all. J Obstet Gynaecol Res. 2021; 47(6): 1929-1945. doi: 10.1111/jog.14787
Akhmetova ES, Mochalova MN, Chatskis EM, Mudrov VA. Diabeticheskaya fetopatiya: sovremenny`e vozmozhnosti prognozirovaniya i profilaktiki. Zabajkalskij meditsinskij vestnik. 2016; 3: 17-24. Russian (Ахметова Е.С., Мочалова М.Н., Чатскис Е.М., Мудров В.А. Диабетическая фетопатия: современные возможности прогнозирования и профилактики //Забайкальский медицинский вестник. 2016. № 3. С. 17-24)
Moraitis AA, Shreeve N, Sovio U, Brocklehurst P, Heazell AEP, Thornton JG, et al. Universal third-trimester ultrasonic screening using fetal macrosomia in the prediction of adverse perinatal outcome: A systematic review and meta-analysis of diagnostic test accuracy. PLoS Med. 2020; 17(10): e1003190. doi: 10.1371/journal.pmed.1003190
O'Malley EG, Reynolds CME, Killalea A, O'Kelly R, Sheehan SR, Turner MJ. Comparison of ultrasound with biomarkers to identify large-for-gestational age in women screened for gestational diabetes mellitus. J Matern Fetal Neonatal Med. 2022; 35(25): 6306-6311. doi: 10.1080/14767058.2021.1911993
Zhang Y, Chen L, Zhang L, Wu Y, Li L. Fasting plasma glucose and fetal ultrasound predict the occurrence of neonatal macrosomia ingestational diabetes mellitus. BMC Pregnancy Childbirth. 2023; 23(1): 269. doi: 10.1186/s12884-023-05594-6
Tong J-N, Wu L-L, Chen Y-X, Guan X-N, Tian F-Y, Zhang H-F, et al. Fasting plasma glucose in the first trimester is related to gestational diabetes mellitus and adverse pregnancy outcomes. Endocrine. 2022; 75(1): 70-81. doi: 10.1007/s12020-021-02831-w
Guo F, Liu Y, Ding Z, Zhang Y, Zhang C, Fan J. Observations of the Effects of Maternal Fasting Plasma Glucose Changes in Early Pregnancy on Fetal Growth Profiles and Birth Outcomes. Front Endocrinol (Lausanne). 2021; 12: 666194. doi: 10.3389/fendo.2021.666194
Antoniou M-Ch, Gilbert L, Gross J, Rossel J-B, Fumeaux CJF, Vial Y, Puder JJ. Potentially modifiable predictors of adverse neonatal and maternal outcomes in pregnancies with gestational diabetes mellitus: can they help for future risk stratification and risk-adapted patient care? BMC Pregnancy Childbirth. 2019; 19(1): 469. doi: 10.1186/s12884-019-2610-2
Muhuza MPU, Zhang L, Wu Q, Qi L, Chen D, Liang Z. The association between maternal HbA1c and adverse outcomes in gestational diabetes. Front Endocrinol (Lausanne). 2023; 14: 1105899. doi: 10.3389/fendo.2023.1105899
Guo Z-H, Tian H-L, Zhang X-Q, Zhang D-H, Wang Z-M, Wang K, et al. Effect of anemia and erythrocyte indices on hemoglobin A1c levels among pregnant women. Clin Chim Acta. 2022; 534: 1-5. doi: 10.1016/j.cca.2022.07.002
Hashimoto K, Koga M. Influence of Iron Deficiency on HbA1c Levels in Pregnant Women: Comparison with Non-Pregnant Women. J Clin Med. 2018; 7(2): 34. doi: 10.3390/jcm7020034
Russell NE, Higgins MF, Kinsley BF, Foley ME, McAuliffe FM. Heart rate variability in neonates of type 1 diabetic pregnancy. Early Hum Dev. 2016; 92: 51-55. doi: 10.1016/j.earlhumdev.2015.11.003
Fehlert E, Willmann K, Fritsche L, Linder K, Mat-Husin H, Schleger F, et al. Gestational diabetes alters the fetal heart rate variability during an oral glucose tolerance test: a fetal magnetocardiography study. BJOG. 2017; 124(12): 1891-1898. doi: 10.1111/1471-0528.14474
Zöllkau J, Swiderski L, Schmidt A, Weschenfelder F, Groten T, Hoyer D, Schneider U. The Relationship between Gestational Diabetes Metabolic Control and Fetal Autonomic Regulation, Movement and Birth Weight. J Clin Med. 2021; 10(15): 3378. doi: 10.3390/jcm10153378